Glenn S Bauman
Overview
Explore the profile of Glenn S Bauman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
2545
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palma D, Giuliani M, Correa R, Schneiders F, Harrow S, Guckenberger M, et al.
BMC Palliat Care
. 2024 Sep;
23(1):223.
PMID: 39244532
Background: Emerging randomized data, mostly from phase II trials, have suggested that patients with oligometastatic cancers may benefit from ablative treatments such as stereotactic ablative radiotherapy (SABR). However, phase III...
2.
Nguyen T, Ramadan S, Palma D, Corkum M, O Neil M, Celinski A, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jul;
120(5):1231-1238.
PMID: 38986914
Purpose: This phase 1 study aimed to assess the safety and feasibility of SABR therapy delivery to all sites of polymetastatic disease (>10 metastases). Methods And Materials: A 3 +...
3.
Mendez L, Crook J, Martell K, Schaly B, Hoover D, Dhar A, et al.
Int J Radiat Oncol Biol Phys
. 2023 Dec;
119(3):803-812.
PMID: 38072323
Objective: The aim of this work was to evaluate the acute toxicity and quality-of-life (QOL) impact of ultrahypofractionated whole pelvis radiation therapy (WPRT) compared with conventional WPRT fractionation after high-dose-rate...
4.
Arifin A, Gulstene S, Warner A, Bauman G, Mendez L
Can Urol Assoc J
. 2023 Aug;
17(8):247-253.
PMID: 37581539
Introduction: Our objective was to assess the effect of F-DCFPyL prostate-specific membrane antigen (PSMA) positron emission tomography (PET) on the management and outcomes of patients receiving salvage radiotherapy following biochemical...
5.
Arifin A, Young S, Bauman G, Fakir H, Ahmad B, Laba J, et al.
Adv Radiat Oncol
. 2023 May;
8(5):101220.
PMID: 37124027
Purpose: The goal of this study was to assess the potential real-world effect of the recently reported SC.24 trial on spine stereotactic body radiation therapy (SBRT) utilization. We estimated the...
6.
Young S, Phaterpekar K, Tsang D, Boldt G, Bauman G
Adv Radiat Oncol
. 2023 Apr;
8(4):101189.
PMID: 37008255
Purpose: The aim of this study was to comprehensively review all studies examining clinical outcomes of craniospinal irradiation with proton radiotherapy for medulloblastoma (MB) to determine whether theoretical dosimetric advantages...
7.
Alfano R, Bauman G, Gomez J, Gaed M, Moussa M, Chin J, et al.
Eur J Radiol
. 2022 Sep;
156:110494.
PMID: 36095953
Background: Multi-parametric magnetic resonance imaging (mp-MRI) is emerging as a useful tool for prostate cancer (PCa) detection but currently has unaddressed limitations. Computer aided diagnosis (CAD) systems have been developed...
8.
Eansor P, Norris M, Dsouza L, Bauman G, Kassam Z, Leung E, et al.
Pract Radiat Oncol
. 2022 Jun;
12(6):e486-e492.
PMID: 35690353
Purpose: Although several different contouring instructional programs are available to radiation oncologists and trainees, very little is known about which methods and resources benefit learners most, and whether some learners...
9.
Harrow S, Palma D, Olson R, Gaede S, Louie A, Haasbeek C, et al.
Int J Radiat Oncol Biol Phys
. 2022 Jun;
114(4):611-616.
PMID: 35643253
Purpose: Long-term randomized data assessing the effect of ablative therapies in patients with oligometastases are lacking. The Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastases (SABR-COMET) randomized phase 2...
10.
Smith C, Marcus T, Hoover D, Surry K, DSouza D, Cool D, et al.
Brachytherapy
. 2022 Mar;
21(4):435-441.
PMID: 35337747
Purpose: Multiparametric magnetic resonance imaging (mpMRI) has demonstrated the ability to localize intraprostatic lesions. It is our goal to determine how to optimally target the underlying histopathological cancer within the...